Biological Age Insights
Exploring the potential of bioregulator peptides, a clinical trial aims to reverse systemic biological age while measuring telomeres and DNA. The discussion highlights the need for specific assessments of skin biological age, given its unique exposure to environmental factors. Additionally, the conversation touches on the benefits of using Os one consistently for addressing cellular senescence, contrasting it with the careful pulsing required for stronger senolytics like rapamycin.In this clip
From this podcast
LONGEVITY with Nathalie Niddam
Episode #58: Turning Back The Clock On Aging Skin With OneSkin’s CEO & Co-Founder Carolina Reis.
Related Questions